Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
huMAb OX40L in Mild Allergic Asthma
NCT00983658Phase 2Completed
- Sponsor
- Genentech
- Start
- Sep 2009
- Primary completion
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 2 trial of oxelumab in asthma, sponsored by Genentech. Started Sep 2009; status: completed.
02
Drugs
oxelumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00983658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983658.